T80.30XA ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter

Name of the Condition

• ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter.

Summary

This condition describes an adverse reaction resulting from the transfusion of blood or blood products that are incompatible with the recipient's ABO blood group. It is a serious complication that can occur when the donor's red blood cells react with the recipient's antibodies, leading to hemolysis and potential organ damage. The reaction is classified as "unspecified" when the exact nature of the incompatibility is not detailed, and "initial encounter" indicates the first episode of care for this reaction.

Causes

ABO incompatibility reactions occur when the recipient's immune system recognizes donor red blood cells as foreign due to mismatched ABO antigens. This triggers an immune response, causing the destruction of the transfused cells. The reaction may result from errors in blood typing, crossmatching, or administration of incorrect blood products.

Risk Factors

• Incorrect blood typing or crossmatching prior to transfusion
• Human error during blood product preparation or administration
• Use of emergency or uncrossmatched blood products
• Pre-existing antibodies against ABO antigens (e.g., in patients with prior transfusions or pregnancies)

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Shortness of breath or respiratory distress
• Jaundice or pallor
• Nausea, vomiting, or headache

Diagnosis

Diagnosis involves correlating clinical symptoms with the timing of the transfusion, laboratory tests to detect hemolysis (e.g., elevated bilirubin, decreased haptoglobin), and confirmation of ABO incompatibility through blood typing and crossmatching. Direct antiglobulin testing may also be performed to identify antibody-mediated destruction of red blood cells.

Treatment Options

Treatment focuses on stopping the transfusion immediately, providing supportive care (e.g., fluids, oxygen), and managing hemolysis. Interventions may include diuretics to prevent kidney damage, transfusion of compatible blood products, and monitoring for complications such as acute kidney injury or disseminated intravascular coagulation (DIC).

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Mild cases may resolve with supportive care, while severe reactions can lead to organ failure or death. Follow-up includes monitoring kidney function, hemoglobin levels, and ensuring no further incompatible transfusions occur.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or cardiovascular collapse
• Multi-organ failure
• Death (in severe cases)

Lifestyle & Prevention

Prevention relies on strict adherence to blood typing and crossmatching protocols, double-checking blood products before administration, and using barcoding or electronic verification systems to minimize human error. Patients with a history of transfusion reactions should have their blood type and antibody status documented clearly.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, chills, shortness of breath, or dark urine occur during or after a blood transfusion. These may indicate a severe incompatibility reaction requiring urgent intervention.

Tips for Medical Coders

Document the specific blood product transfused, the timing of the reaction, and whether it is the initial encounter. Ensure the code T80.30XA is used only when the ABO incompatibility is unspecified and the encounter is initial. Include details about the transfusion process and any contributing factors (e.g., errors in blood matching) to support the diagnosis.